Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Male breast cancer is a rare malignancy that accounts for less than 1% of all cancers in men
and less than 1% of all breast cancers. But the incidence is rising and in some patient …

Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Purpose Because of its rarity, male breast cancer is often compared with female breast
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …

Male breast cancer (MaleBC) is a rare disease, accounting for< 1% of all male tumors.
During the last few years, there has been an increase in the incidence of this disease, along …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Background BRCA1 and, more commonly, BRCA2 mutations are associated with increased
risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of …

Male breast cancer (MBC) is extremely rare, with an incidence in the general US population
of< 1%. It tends to be diagnosed at later stages than breast cancer in females, likely because …

Male breast cancer (MBC) is an uncommon disease with a frequency of approximately one
in 1000. Due to the rarity of MBC, it is understudied and its etiology is poorly understood. Our …

Background and study design Male breast cancer (MBC) is a rare disease compared with
female BC and our current understanding regarding breast carcinogenesis in men has been …